We are a clinical-stage biopharmaceutical company leveraging our technology platform to develop systemically delivered, tissue targeted therapeutics | $SBTX
Seattle, WA
Joined December 2017
- Tweets122
- Following173
- Followers187
- Likes26
Our CEO, Laura Shawver (@lshawverO), will be presenting at the H.C. Wainwright (@HCWCO) 24th Annual Global Investment Conference. Tune in tomorrow, May 24th at 7:00 a.m. ET / 4:00 a.m. PT to hear the live webcast. bit.ly/3MFRdQ5 $SBTX
Our Silverback team was treated to #espresso drinks from Gourmet Espresso Catering (@mobilespresso). Thank you, Gourmet Espresso Catering, for bringing our team together! #OurStrengthIsOurPeople
Our Silverback management team will be participating in the H.C. Wainwright (@HCWCO) 24th Global Investment Conference from May 23-25, 2022. Learn more here: bit.ly/3Nobn0D $SBTX
Today, we announced our Q1 2022 financial results and provided a business update. Visit the ‘News & Events’ section of our website to learn more: bit.ly/3FDMBai $SBTX
May is #HepatitisAwarenessMonth – a time to recognize the global impact of hepatitis B and the need for increased testing, diagnosis & treatment. At Silverback, we are #SeekingVictory for the ~300M patients globally with chronic #HepB through our #SBT8230 program.
Activation of #TLR8 can elicit a robust immune response, critical for mounting productive anti-tumor and anti-viral responses, through a multi-pronged mechanism of action.
Today, our CEO, Laura Shawver (@lshawverO), will be presenting a corporate overview at the 42nd Annual @Cowen_Inc Healthcare Conference. Tune in at 9:50 a.m. PT / 12:50 p.m. ET to hear the live webcast. bit.ly/3uX3Zkh $SBTX
In honor of #InternationalWomensDay & #WomensHistoryMonth, we are recognizing the importance of having a diverse workforce with strong female leaders & employees. Hear from Silverback members on what #IWD & #WHM means to them.
The Cancer Moonshot initiative is a noble cause with the goal of cutting cancer death in half over the next 25 years.
At Silverback, we see immunotherapy as an important tool in the future of cancer treatment. We are focused on developing innovative, tissue-targeted immunotherapies that activate myeloid cells & stimulate an immune response against cancer. bit.ly/3ruqOMN #CancerMoonshot
Our CEO, Laura Shawver (@lshawverO), and President & CSO, Valerie Odegard, will be participating in a fireside chat at the @SVBLeerink 11th Annual Global Healthcare Conference today at 10:00 a.m. PT / 1:00 p.m. ET. View the webcast here: bit.ly/3gqHluY
Today, our CEO, Laura Shawver (@lshawverO), will be participating in an @endpts webinar entitled, “The top 100 VCs in biotech 2022” moderated by @JohnCendpts at 11:00 a.m. PT / 2:00 p.m. ET. Learn more and register here: bit.ly/3J3tWFl
Today is #WorldCancerDay – With the theme #CloseTheCareGap, we recognize that everyone deserves access to cancer care. At Silverback, we are proud to have two clinical-stage programs in oncology with a TLR8 agonist payload targeting myeloid cells in the tumor microenvironment.
Grateful for the pioneers of immunotherapy whose enduring discoveries have brought hope to cancer patients everywhere. #WorldCancerDay
"This isn't just a cancer therapy. This is a way of liberating people from the burden of having a disease that could come back and kill you."
On #WorldCancerDay, our 2018 medicine laureates reflect on the hope their remarkable cancer therapy gives to patients around the globe.
Join a team of individuals who love working together, set the bar high and are dedicated to developing new therapies for patients with cancer and other serious diseases. View open positions here: bit.ly/3K3iCKJ
On Martin Luther King Jr. Day – our team honors the life and legacy of Dr. King who focused his efforts on encouraging people to fight racial inequality and build stronger communities. #MLKDay
At Silverback, our mission is to seek victory for patients by developing novel, tissue-targeted therapies designed to result in life changing outcomes. As we enter 2022, we remind ourselves & our patient community of the values that guide us in our work. bit.ly/3pkP9DA
Our CEO, Laura Shawver (@lshawverO), and CSO and President, Valerie Odegard, provided a corporate overview at the @HCWCO Bioconnect 2022 Conference today. See the full webcast here: bit.ly/3uX3Zkh $SBTX
